Trial · NCT07905716
Comparative Effects of Sensorimotor Training and tACS on Upper Limb Function and Cervical Proprioception in Subacute Stroke
NCT07905716, Not applicable, Active not recruiting, University of Management and Technology Lahore
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparative Effects of Sensorimotor Training and tACS on Upper Limb Function and Cervical Proprioception in Subacute Stroke. Trials, record NCT07905716. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07905716
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparative Effects of Sensorimotor Training and tACS on Upper Limb Function and Cervical Proprioception in Subacute Stroke
- NCT number
- NCT07905716
- Status
- Active not recruiting
- Phases
- Not applicable
- Enrollment
- 38 participants, actual
- Lead sponsor
- University of Management and Technology Lahore
- Conditions
- Sub-acute Stroke
- Interventions
- sensorimotor training with TACS, sensorimotor training with Sham TACS
- First posted
- 2026-10-29
- Last updated
- 2026-11-03
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | joint position sense through Cervical joint position test | at base line and after 4 weeks | The Cervical Joint Position Error (JPE) Test is a measurement tool used to clinically assess an individual's cervicocephalic proprioception ability. The patient sits 90 cm from a wall-mounted target and wears a headband with a laser pointer. After recording the neutral starting position, the patient closes their eyes, moves their head in rotation (left/right), flexion, or extension, and returns to the starting position. The test is repeated three times in each direction, and the average repositioning error is calculated. A repositioning error greater than 4.5° (approximately 7 cm) indicates impaired cervical proprioception. |
| Primary | somatosensory impairment through Revised Nottingham Sensory Assessment Scale | at base line and after 4 weeks | The rNSA examines somatosensory impairment using a 3-point scale (0 =absent, 1 = impaired, 2 = normal) and takes approximately 25-35 min to complete. It consists of 72 items and is grouped into three sub-scales. Tactile Sensation 54 Points \< 54 Points indicates a deficit ,Kinesthesia 12 Point \< 12 Points indicates a deficit., Stereognosis 22 Points \< 19 Points indicates impairment. |
| Primary | Fugyl-Meyer Assessment for upper extremity (FMA-UE) | at base line and after 4 weeks | Fugyl-Meyer Assessment (FMA) scale is an index to assess sensorimotor impairments who have had stroke. The Fugyl-Meyer Assessment for upper extremity (FMA-UE) has been tested extensively, and is found to have excellent psychometric properties. For upper extremity assessment, Rating is from 0-50 with 0-25 points showing severe impairment and 26-50 points showing moderate impairment. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 37994674 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07905716
GET https://conductscience.org/api/trials/v1/NCT07905716/registered